As described earlier, four cancers with a high mutation burden (SKCM-metastatic, SKCM-primary, LUAD and UCEC) had the largest percentages (46%, 29%, 19% and 10%, respectively) of tumors with two or more mutations from UGT genes. Here, SLC35A2 is linked to cancer.